术后使用加巴喷丁类药减少长节段腰椎内固定术后长期阿片类药物依赖:一项回顾性倾向匹配分析
该回顾性队列分析查询TriNetX研究网络,纳入接受3至12节段后路腰椎内固定的腰椎管狭窄、滑脱或脊柱侧凸患者,按术后30天内是否处方加巴喷丁类药分组并行1:1倾向评分匹配,评估术后多个时间段阿片类药物处方情况。结果显示在3至6节段组中,术后早期使用加巴喷丁类药与所有术后时间段非可待因类及强阿片类药物处方几率显著降低相关,但在7至12节段组中任何时间段均未观察到显著差异。
要点
- 3至6节段内固定患者术后30天内使用加巴喷丁类药,所有术后时间段非可待因类及强阿片类药物处方几率显著降低。
- 3至6节段组中,使用加巴喷丁类药的患者在术后3至6个月弱阿片类药物处方几率较高。
- 7至12节段内固定患者中,加巴喷丁类药与阿片类药物处方在任何时间段均无统计学显著差异。
核心结论
- 术后早期处方加巴喷丁类药与3至6节段腰椎融合术后长期非可待因类及强阿片类药物使用持续减少相关。
- 这些发现强调加巴喷丁类药作为多模式镇痛策略一部分的效用,可能减少对更强效阿片类药物的需求并降低脊柱手术患者长期依赖风险。
研究设计与样本
- 回顾性队列分析,查询TriNetX研究网络,纳入术前诊断为腰椎管狭窄、腰椎滑脱或脊柱侧凸并接受后路腰椎内固定跨越3至12个椎节段的患者。
- 按内固定范围分为3至6节段组和7至12节段组,每组再按术后30天内是否处方加巴喷丁类药(加巴喷丁或普瑞巴林)分为两队列。
- 采用1:1倾向评分匹配调整人口学特征、合并症及术前阿片类和加巴喷丁类药处方,初始纳入28827例患者;匹配后3至6节段组每队列1816例,7至12节段组每队列344例。
主要发现
- 在3至6节段内固定患者中,术后30天内接受加巴喷丁类药的患者在所有术后时间段(1至3个月、3至6个月、6至12个月、12至24个月)非可待因类及强阿片类药物处方几率显著降低。
- 在3至6节段内固定患者中,接受加巴喷丁类药的患者在术后3至6个月弱阿片类药物处方几率较高。
- 在7至12节段内固定患者中,任何时间段均未观察到阿片类药物处方有统计学显著差异。
临床怎么用
- 作者认为,术后早期处方加巴喷丁类药与3至6节段腰椎融合术后长期非可待因类及强阿片类药物使用持续减少相关。
- 作者指出,这些发现强调加巴喷丁类药作为多模式镇痛策略一部分的效用,可能减少对更强效阿片类药物的需求并降低脊柱手术患者长期依赖风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY DESIGN: A retrospective cohort analysis. OBJECTIVE: This study investigates the association between initial postoperative gabapentinoid prescription and long-term opioid use following long-segment posterior lumbar instrumentation. BACKGROUND: Gabapentinoids have gained traction for their neuropathic pain-relieving properties and potential synergy with opioids. However, their long-term efficacy in minimizing postoperative opioid consumption remains uncertain, particularly in patients undergoing extensive spinal surgery. MATERIALS AND METHODS: The TriNetX Research Network was queried to identify patients with preoperative diagnoses of lumbar spinal stenosis, spondylolisthesis or scoliosis who underwent posterior lumbar instrumentation spanning 3 to 12 vertebral segments. The study population was stratified by based on the extent of instrumentation, defined as either 3 to 6 or 7 to 12 spinal segments. These patients were further divided into two cohorts: those who were prescribed a gabapentinoid (gabapentin or pregabalin) within 30 days postoperatively and those who were not. To address potential confounders, 1:1 propensity score matching (PSM) was performed, adjusting for demographics, comorbidities, and preoperative prescriptions of opioids and gabapentinoids. Presence of select postoperative opioid prescriptions was assessed at 1 to 3 months, 3 to 6 months, 6 to 12 months, and 12 to 24 months. RESULTS: A total of 28,827 patients met all initial inclusion criteria. Following 1:1 PSM, the 3 to 6 segment group included 1,816 patients per cohort, and the 7 to 12 segment group consisted of 344 patients per cohort. Among 3 to 6 level instrumentations, patients who received gabapentinoids within 30 days of surgery demonstrated significantly lower odds of being prescribed non-codeine-based and strong opioids at all postoperative intervals. In contrast, these gabapentinoid-treated patients exhibited higher odds of weak opioid prescriptions at 3 to 6 months. No statistically significant difference in opioid prescribing was observed among 7 to 12 segment instrumentation patients at any period. CONCLUSION: This study demonstrates that early postoperative gabapentinoid prescription is associated with a sustained reduction in chronic non-codeine-based and strong opioid use following 3 to 6 segment lumbar fusion. These findings underscore the utility of gabapentinoids as part of a multimodal analgesia strategy, potentially minimizing the need for more potent opioids and reducing the risk of long-term dependence in spine surgery patients.
引用
- Karnati J, Wu A, Tao X, et al. Postoperative Gabapentinoid Use Reduces Long-Term Opioid Reliance After Long-Segment Lumbar Instrumentation: A Retrospective Propensity-Matched Analysis. Spine (Phila Pa 1976). 2025. PMID: 40844769. doi:10.1097/BRS.0000000000005480
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。